CAS: 2567-29-5; 4-(Bromomethyl)-1,1'-Biphenyl

该化合物是一种有机化合物,其特点是存在一种以溴乙基组替代的双联苯结构,这种化合物由于其芳香的双联骨骨质,通常具有非极性,这助长了其疏水性能;溴乙基替代成分既具有溴功能,又具有乙基功能,可以影响其在各种溶剂中的再活性和溶性;溴乙基联苯可因溴原子的电子提取性质而参与电子嗜热替代反应,从而有可能成为进一步化学变异的候选物;其物理特性,如熔点,沸点和密度,受到分子结构和分体特性的影响;此外,这种化合物可能适用于有机合成,材料科学,或作为其他化学实体生产的中间体;在处理和储存时,应参考安全数据,因为卤化化合物可能对环境和健康造成风险.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号3597-91-9 4-联苯甲醇 | CAS号589-15-1 对溴溴苄 | CAS号98-80-6 苯硼酸 | CAS号644-08-6 4-甲基联苯 | CAS号16004-15-2 对碘溴苄 | CAS号768-59-2 4-乙基苄醇 | CAS号92-92-2 4-苯基苯甲酸 | CAS号108-86-1 溴苯 | CAS号5720-05-8 对甲基苯基硼酸 | CAS号4748-78-1 4-乙基苯甲醛 | CAS号1432-30-0 2-[2-(4-phenylp... | CAS号21326-80-7 1,2-二([1,1'-联苯]... | CAS号92-92-2 4-苯基苯甲酸 | CAS号2920-38-9 4-氰基联苯 | CAS号3218-36-8 4-联苯甲醛 | CAS号644-08-6 4-甲基联苯 | CAS号31603-77-7 4-联苯乙腈 | CAS号63024-23-7 Dl-3-(4-联苯)丙氨酸盐酸盐 | CAS号69605-90-9 3-联苯甲醇 | CAS号76985-08-5 2-氨基-3-(4-联苯基)丙酸

合成工艺路线路线简述

    4-苯基苯甲酸置于n-溴代丁二酰亚胺(Nbs),Lithium Aluminium Tetrahydride,硫酸,三苯基膦体系中,用 四氢呋喃,二氯甲烷 用作溶剂,化学反应生成4-溴甲基联苯
    参考文献:钴催化末端炔烃的 1,1,3-三甲基化
    标题:钴催化末端炔烃的 1,1,3-三甲基化
    摘要:我们开发了一种钴催化的末端炔烃与频哪醇硼烷 (Hbpin) 的区域选择性 1,1,3-三苯甲基化反应,催化剂由容易获得且工作稳定的 Co(Acac) 2原位生成和黄磷.多种末端炔烃经历此三苯甲基化反应,以高收率和高选择性提供相应的 1,1,3-三硼烷基烷烃.该催化协议的合成效用已通过开发 1,1,3-三苯烷基烷产品的选择性逐步功能化得到证明.进行对照实验和氘标记反应,监测反应过程和识别反应中间体等机理研究的结果表明,这种 1,1,3-三硼化反应通过 Alken-1-的 1,3-二硼化进行的.由钴催化的末端炔烃的硼氢化形成的基硼酸盐.
    Doi:10.1021/acs.Organomet.2C00053

    海关参考信息

    专利信息


    专利号:US-8710261-B2
    优先权日:2005-02-22
    标 题:5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
    发明人:PALLE VENKATA P; SATTIGERI VISWAJANANI JITENDRA; KHERA MANOJ KUMAR; VOLETI SREEDHARA RAO; RAY ABHIJIT; DASTIDAR SUNANDA G
    权利人:PALLE VENKATA P; SATTIGERI VISWAJANANI JITENDRA; KHERA MANOJ KUMAR; VOLETI SREEDHARA RAO; RAY ABHIJIT; DASTIDAR SUNANDA G; RANBAXY LAB LTD
    摘要:The present invention relates to Compounds having the structure of Formula I: wherein n is an integer from 1 to 5; R 1 is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl, heteroaryl, aralkyl, alkoxy, aryloxy, alkenyloxy or alkynyloxy; R 2 is alkenyl, allcynyl, aryl, heterocyclyl, heteroaryl, cycloalkyl, NR 4 R 5 , —NHC(â•?Y)R 4 , —NHC(â•?Y)NR 5 R χ , —NHC(â•?O)OR 4 , —NHSO 2 R 4 , C(â•?Y)NR 4 R 5 , C(â•?O)OR 6 [wherein Y is oxygen or sulphur], OR 5 , —O(Câ•?O)NR 4 R 5 , O-acyl, S(O) m R 4 , —SO 2 N(R 4 ) 2 , cyano, amidino or guanidino [wherein R 4 is alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl, heteroaryl, aralkyl, heteroarylalkyl, heterocyclylalkyl or cycloalkylalkyl and m is an integer 0-2; R 5 is hydrogen or R 4 ; R x is R 4 or —SO 2 N(R 4 ) 2 and R 6 is hydrogen, alkyl, cycloalkyl, aralkyl, heteroarylalkyl, heterocyclylalkyl or cycloalkylalkyl]; R 3 is hydrogen, fluorine, alkyl, cycloalkylalkyl or aralkyl; A is OH, OR 4 , —OC(â•?O)NR 4 R 5 , O-acyl, NH 2 , NR 4 R 5 , —NHC(â•?Y)R 4 , —NHC(â•?Y)NR 5 R x , —NHC(â•?O)OR 4 , —NHSO 2 R 4 , and to processes for the synthesis of the same. This invention also relates to pharmacological compositions containing the compounds of the present invention, and methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis pulmonary inflammation, acute respiratory distress syndrome, perodontitis, multiple sclerosis, gingivitis, atherosclerosis, neointimal proliferation, which leads to restenosis and ischemic heart failure, stroke, renal diseases, tumor metastasis, and other inflammatory disorders characterize by over-expression and over-activation of an matrix metalloproteinase, using the compounds.

    专利号:US-5932743-A
    优先权日:1997-08-21
    标 题:Methods for the solid phase synthesis of substituted indole compounds
    发明人:COLLINI MICHAEL D; ELLINGBOE JOHN W
    权利人:AMERICAN HOME PROD
    摘要:The present invention relates to novel substituted indole compounds of formula (I) having pharmacological activity, to processes for their preparation, to solid phase methods for preparing libraries of the compounds, to utilizing libraries of the compounds for drug discovery, and to pharmaceutical compositions thereof.

    专利号:US-2020181095-A1
    优先权日:2017-06-06
    标题:Selective matrix metalloproteinase-13 inhibitors
    发明人:FIELDS GREGG B; ROUSH WILLIAM R; CHOI JUN YONG; FUERST RITA
    权利人:FLORIDA ATLANTIC UNIV BOARD OF TRUSTEES; SCRIPPS RESEARCH INST
    摘要:We describe the use of comparative structural analysis and structure-guided molecular design to develop potent and selective inhibitors (10d and (S)-17b) of matrix metalloproteinase 13 (MMP-13). We applied a three-step process, starting with a comparative analysis of the X-ray crystallographic structure of compound 5 in complex with MMP-13 with published structures of known MMP-13 inhibitor complexes followed by molecular design and synthesis of potent, but non-selective zinc-chelating MMP inhibitors (e.g., 10a and 10b). After demonstrating that the pharmacophores of the chelating inhibitors (S)-10a, (R)-10a, and 10b were binding within the MMP-13 active site, the Zn2+ chelating unit was replaced with non-chelating polar residues that bridged over the Zn2+ binding site and reach into a solvent accessible area. After two rounds of structural optimization, these design approaches led to small molecule MMP-13 inhibitors 10d and (S)-17b which bind within the substrate-binding site of MMP-13 and surround the catalytically active Zn2+ ion without chelating to the metal. These compounds exhibit at least 500-fold selectivity versus other MMPs.

    专利号:WO-9909007-A1
    优先权日:1997-08-21
    标题:Solid phase synthesis of 2,3-disubstituted indole compounds
    发明人:COLLINI MICHAEL DAVID; ELLINGBOE JOHN WATSON
    权利人:AMERICAN HOME PROD
    摘要:The present invention relates to novel substituted indole compounds of formula (I) having pharmacological activity, to processes for their preparation, to a combinatorial library and solid phase methods for preparing libraries of the compounds, to utilizing libraries of the compounds for drug discovery, and to pharmaceutical compositions thereof.

    专利号:US-5693720-A
    优先权日:1994-03-22
    标 题:Solid-phase synthesis utilizing photochemical carbon-sulfur bond cleavage of thioethers
    发明人:SUCHOLEIKI IRVING
    权利人:LILLY CO ELI
    摘要:A method for photochemical cleavage of carbon-sulfur bonds in conjunction with solid-phase synthesis utilizing a deoxygenated solvent and light to cleave the carbon-sulfur bond from a heterogeneous support. Also disclosed are compounds for use with said photochemical cleavage and methods of preparing them.

    专利号:US-11767302-B2
    优先权日:2020-10-01
    标题 :Reagents and methods for tetrazine synthesis
    发明人:FOX JOSEPH M; LAMBERT WILLIAM; FANG YINZHI; AM ENDE CHRISTOPHER WILLIAM; MAHAPATRA SUBHAM; XIE YIXIN; WANG CHUANQI
    权利人:UNIV DELAWARE
    摘要:Disclosed herein are mono- and di-substituted tetrazines and methods of their preparation and converting an oxetanyl ester to a thio-substituted tetrazine, which is then converted to a mono-substituted tetrazine, a di-substituted tetrazine, or a vinylether disubstituted tetrazine.
    无锡惠飞生物医药技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.huifeichem.com
    电话: 0510-0510-83593305👤
    📞无锡惠飞生物医药技术有限公司 ⚠️参考联系方式

    销售电话:0510-0510-83593305
    邮箱:sales@huifeichem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    河南紫罗兰科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.violettech.net
    电话: 13409345566👤
    📞河南紫罗兰科技有限公司 ⚠️参考联系方式

    销售电话:13409345566
    邮箱:3392861550@qq.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州威尔迅贸易有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.well-win.com.cn
    电话: 0086 (571) 8839-1072👤
    📞杭州威尔迅贸易有限公司 ⚠️参考联系方式

    销售电话:0086 (571) 8839-1072
    邮箱:sales@well-win.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Lemière, G.; Clayden, J., Science of Synthesis Knowledge Updates, (2011) 4, 176.
    摘要:Mérour, J.-Y.; Joseph, B., Science of Synthesis Knowledge Updates, (2016) 3, 118.
    摘要:Wang, K.; Wang, J., Science of Synthesis, (2022) , 15.
    摘要:Shirakawa, S.; Maruoka, K., Science of Synthesis: Asymmetric Organocatalysis, (2012) 2, 571.
    摘要:Yerien, D. E.; Barata-Vallejo, S.; Postigo, A., Science of Synthesis: Modern Strategies in Organofluorine Chemistry , (2024) 1, 41.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知